FDA Asks 5 Diabetes Drug Manufacturers to Recall Their Medications

NDMA, a cancer-causing contaminant, has been found in more diabetes medications, and now the U.S. Food and Drug Administration is asking five pharmaceutical companies to recall their drugs due to the risks they may pose to consumers.

The affected drug is called Metformin, and it’s used to treat type 2 diabetes. Thus far, drug marker Apotex has already announced that it will recall its affected medications. NDMA contamination in Metformin products was first reported in early 2020. Prior to that, it was found in high blood pressure medications, including losartan, and acid reflux medications, including Zantac.

Although NDMA is present in many naturally occurring substances and foods, including cured and grilled meats, dairy products, and vegetables, humans should only ingest a small amount per day. Health agencies have established that number as around 96 nanograms per day. When products exceed that level, daily use could put patients at a higher risk of developing certain types of cancer due to NDMA being a known carcinogen.

As always, never stop taking a medication without talking to your doctor first. The risks associated with suddenly discontinuing a medication without replacing it with another medication can be greater than the risks posed by the recalled medication.

But if you or someone you love was harmed by a defective or recalled medication, the drug injury lawyers at Ferrer, Poirot & Wansbrough want to help. Contact us today for a free consultation. It’s our job to get you the compensation you’re owed.